The Effects Of Tibolone In Older Postmenopausal Women

The recent report from the LIFT study1, a large, randomized, controlled trial of the hormone replacement therapy (HRT) tibolone in older postmenopausal women with osteoporosis, provides some good news and some bad news. The primary aim of the study was to confirm that tibolone reduces the risk of osteoporotic vertebral fracture.

More: continued here

Filed under: Endocrinology on September 8th, 2008